ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MO vs UNH // REVENUE GROWTH (YOY)

Altria Group Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: MO 10 — UNH 4
▲ REVENUE GROWTH (YOY) LEADER: UNH
revenue-growth
-3.10%
revenue-growth
3.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MO VS. UNH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MO UNH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.50% 88.31% -25.81 UNH /gross-margins <GO>
Return on Invested Capital (ROIC) 48.40% 12.38% +36.02 MO /roic <GO>
EV/EBITDA & P/E Valuation 14.7x 15.3x -0.57 MO /valuation <GO>
Free Cash Flow Yield 7.08% 6.25% +0.83 MO /fcf-yield <GO>
Operating Margin 42.50% 5.32% +37.18 MO /operating-margins <GO>
Net Profit Margin 29.80% 3.53% +26.27 MO /net-margins <GO>
Revenue Growth (YoY) ACTIVE -3.10% 3.33% -6.43 UNH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 5.43% 2.29% +3.14 MO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.90 3.09 +1.81 MO /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 UNH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — 7.00% — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 62.8 55.1 +7.70 MO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.92 0.33 +0.59 MO /macro-sensitivity <GO>
Forward P/E Multiple 17.1x 17.7x -0.64 MO /forward-pe <GO>
Enterprise Scale & Market Cap $128.37B $359.43B -$231.07B UNH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MO REV UNH REV MO GROSS % UNH GROSS % MO FCF UNH FCF
FY 2025 $23.28B $447.57B 62.5% 88.7% $9.07B $16.07B
FY 2024 $24.02B $400.28B 59.8% 88.3% $8.61B $20.70B
FY 2023 $24.48B $371.62B — 89.6% $8.19B $25.68B
FY 2022 — $324.16B — 89.6% — $23.40B
FY 2021 — $287.60B — 89.2% — $19.89B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MO // BETA 0.92
UNH // BETA 0.33